Epiliquid Holding, Inc
3 clinical trials · Sponsor
◉ Watch Epiliquid Holding, Inc
| Record | Firm | Date |
|---|---|---|
| Colon Cancer Liquid Biopsy Investigation of Methylation-based Biomarkers Evaluation Using Delta-HLD (CLIMBED) (NCT07168876) | Epiliquid Holding, Inc | 2024-04-04 |
| Hepatocellular Carcinoma Identification Using Delta-HLD (NCT07148310) | Epiliquid Holding, Inc | 2023-05-18 |
| Colorectal Analysis for Signature Cancer Assessment Using Delta-HLD (NCT07148297) | Epiliquid Holding, Inc | 2021-06-30 |
Track Epiliquid Holding, Inc automatically
Every clearance here is in the API, with alerts when new ones post.